Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 11-Jun-24 8:31 PM View:  | Deciphera Pharmaceuticals, ... (NA) | 11-Jun-24 | Grant | 286,075 | -- | -- | 393% 72.76K to 358.84K | |
| 11-Jun-24 8:31 PM View: | Deciphera Pharmaceuticals, ... (NA) | 11-Jun-24 | Disposition | 286,075 | -- | -- | (80%) 358.84K to 72.76K | |
| 11-Jun-24 8:31 PM View: | Deciphera Pharmaceuticals, ... (NA) | 11-Jun-24 | Disposition (change in control) | 72,763 | -- | -- | (100%) 72.76K to 0 | |
| 14-Dec-23 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 13-Dec-23 | Sale | 30,664 | $15.37 | $471,217.00 | (30%) 103.43K to 72.76K | |
| 14-Dec-23 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 12-Dec-23 | Grant | 62,500 | -- | -- | 153% 40.93K to 103.43K | |
| 31-Oct-23 4:09 PM View: | Deciphera Pharmaceuticals, ... (NA) | 30-Oct-23 | Sale | 21,573 | $12.02 | $259,256.00 | (35%) 62.5K to 40.93K | |
| 31-Oct-23 4:09 PM View: | Deciphera Pharmaceuticals, ... (NA) | 28-Oct-23 | Grant | 62,500 | -- | -- | 100% 0 to 62.5K | |
| 23-Mar-23 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 21-Mar-23 | Private Sale (Planned) | 7,500 | $15.57 | $116,782.00 | (100%) 7.5K to 0 | |
| 16-Feb-23 4:18 PM View: | Deciphera Pharmaceuticals, ... (NA) | 14-Feb-23 | Private Sale (Planned) | 30,045 | $16.00 | $480,720.00 | (80%) 37.55K to 7.5K | |
| 23-Mar-22 4:15 PM View: | Deciphera Pharmaceuticals, ... (NA) | 21-Mar-22 | Payment of Exercise | 3,150 | $9.11 | $28,696.50 | (8%) 40.7K to 37.55K | < 1% |
| 22-Mar-21 5:00 PM View: | Deciphera Pharmaceuticals, ... (NA) | 18-Mar-21 | Payment of Exercise | 3,150 | $43.02 | $135,500.00 | (7%) 43.84K to 40.7K | (7%) |
| 25-Jan-21 5:00 PM View: | Deciphera Pharmaceuticals, ... (NA) | 21-Jan-21 | Option Exercise | 1,078 | $25.40 | $27,381.20 | 3% 42.77K to 43.84K | |
| 24-Aug-20 4:00 PM View: | Deciphera Pharmaceuticals, ... (NA) | 20-Aug-20 | Option Exercise | 187 | $25.40 | $4,749.80 | < 1% 42.58K to 42.77K | (9%) |
| 22-Jul-20 4:00 PM View: | Deciphera Pharmaceuticals, ... (NA) | 20-Jul-20 | Option Exercise | 188 | $25.40 | $4,775.20 | < 1% 42.39K to 42.58K | (9%) |
| 19-Jun-20 4:00 PM View: | Deciphera Pharmaceuticals, ... (NA) | 18-Jun-20 | Option Exercise | 187 | $25.40 | $4,749.80 | < 1% 42.2K to 42.39K | (9%) |
| 01-Jun-20 4:05 PM View: | Deciphera Pharmaceuticals, ... (NA) | 28-May-20 | Option Exercise | 188 | $25.40 | $4,775.20 | < 1% 42.02K to 42.2K | (9%) |
| 23-Apr-20 4:10 PM View: | Deciphera Pharmaceuticals, ... (NA) | 21-Apr-20 | Option Exercise | 187 | $25.40 | $4,749.80 | < 1% 41.83K to 42.02K | (9%) |
| 20-Mar-20 5:49 PM View: | Deciphera Pharmaceuticals, ... (NA) | 19-Mar-20 | Payment of Exercise | 12,420 | $37.49 | $465,619.00 | (23%) 54.25K to 41.83K | |
| 20-Mar-20 5:49 PM View: | Deciphera Pharmaceuticals, ... (NA) | 18-Mar-20 | Option Exercise | 2,250 | $25.40 | $57,150.00 | 4% 52.0K to 54.25K | (9%) |
| 20-Mar-19 5:47 PM View: | Deciphera Pharmaceuticals, ... (NA) | 18-Mar-19 | Grant | 52,000 | -- | -- | 100% 0 to 52.0K | |
| 05-Mar-19 4:04 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 04-Mar-19 | Option Exercise | 5,000 | $39.76 | $198,800.00 | 46% 10.94K to 15.94K | |
| 05-Mar-19 4:04 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 04-Mar-19 | Market Option Sale | 5,000 | $68.00 | $340,000.00 | (31%) 15.94K to 10.94K | 38% |
| 05-Mar-19 4:04 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-19 | Option Exercise | 5,000 | $39.76 | $198,800.00 | 46% 10.94K to 15.94K | |
| 05-Mar-19 4:04 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 01-Mar-19 | Market Option Sale | 5,000 | $66.01 | $330,050.00 | (31%) 15.94K to 10.94K | 37% |
| 20-Feb-19 4:06 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 19-Feb-19 | Payment of Exercise | 1,040 | $58.03 | $60,351.20 | (9%) 11.98K to 10.94K | 28% |
| 20-Feb-19 4:06 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 16-Feb-19 | Option Exercise | 2,750 | -- | -- | 30% 9.23K to 11.98K | |
| 23-Jan-19 4:19 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Jan-19 | Payment of Exercise | 5,769 | $52.82 | $304,719.00 | (38%) 15.0K to 9.23K | 21% |
| 23-Jan-19 4:19 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 20-Jan-19 | Option Exercise | 15,000 | -- | -- | 100% 0 to 15.0K | |
| 28-Aug-18 4:06 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 24-Aug-18 | Option Exercise | 2,050 | $39.76 | $81,508.00 | 100% 0 to 2.05K | |
| 28-Aug-18 4:06 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 24-Aug-18 | Market Option Sale (Planned) | 2,050 | $74.92 | $153,586.00 | (100%) 2.05K to 0 | 44% |
| 27-Jul-18 4:01 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 25-Jul-18 | Option Exercise | 2,050 | $39.76 | $81,508.00 | 100% 0 to 2.05K | |
| 27-Jul-18 4:01 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 25-Jul-18 | Market Option Sale (Planned) | 2,050 | $84.58 | $173,389.00 | (100%) 2.05K to 0 | 51% |
| 26-Jun-18 4:02 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Jun-18 | Option Exercise | 2,050 | $39.76 | $81,508.00 | 100% 0 to 2.05K | |
| 26-Jun-18 4:02 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Jun-18 | Market Option Sale (Planned) | 2,050 | $97.58 | $200,039.00 | (100%) 2.05K to 0 | 57% |
| 29-May-18 6:14 AM View: | Agios Pharmaceuticals, Inc. (AGIO) | 23-May-18 | Option Exercise | 2,050 | $39.76 | $81,508.00 | 100% 0 to 2.05K | |
| 29-May-18 6:14 AM View: | Agios Pharmaceuticals, Inc. (AGIO) | 23-May-18 | Market Option Sale (Planned) | 2,050 | $85.76 | $175,808.00 | (100%) 2.05K to 0 | 51% |
| 25-Apr-18 4:12 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 23-Apr-18 | Option Exercise | 2,050 | $39.76 | $81,508.00 | 100% 0 to 2.05K | |
| 25-Apr-18 4:12 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 23-Apr-18 | Market Option Sale (Planned) | 2,050 | $85.95 | $176,198.00 | (100%) 2.05K to 0 | 51% |
| 26-Mar-18 4:01 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Mar-18 | Option Exercise | 2,050 | $39.76 | $81,508.00 | 100% 0 to 2.05K | |
| 26-Mar-18 4:01 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Mar-18 | Market Option Sale (Planned) | 2,050 | $84.65 | $173,532.00 | (100%) 2.05K to 0 | 51% |
| 26-Feb-18 4:45 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Feb-18 | Option Exercise | 2,050 | $39.76 | $81,508.00 | 100% 0 to 2.05K | |
| 26-Feb-18 4:45 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 22-Feb-18 | Market Option Sale (Planned) | 2,050 | $78.63 | $161,192.00 | (100%) 2.05K to 0 | 47% |
| 25-Jan-18 4:03 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 23-Jan-18 | Option Exercise | 25,000 | $39.76 | $994,000.00 | 100% 0 to 25.0K | |
| 25-Jan-18 4:03 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 23-Jan-18 | Market Option Sale (Planned) | 25,000 | $74.83 | $1,870,750.00 | (100%) 25.0K to 0 | 44% |
| 09-Mar-15 7:02 PM View: | Clovis Oncology, Inc. (CLVS) | 05-Mar-15 | Option Exercise | 20,000 | $11.02 | $220,400.00 | 100% 0 to 20.0K | |
| 09-Mar-15 7:02 PM View: | Clovis Oncology, Inc. (CLVS) | 05-Mar-15 | Market Option Sale (Planned) | 20,000 | $80.00 | $1,600,000.00 | (100%) 20.0K to 0 | 94% |
| 19-Feb-15 4:35 PM View: | Clovis Oncology, Inc. (CLVS) | 17-Feb-15 | Option Exercise | 10,000 | $11.02 | $110,200.00 | 100% 0 to 10.0K | |
| 19-Feb-15 4:35 PM View: | Clovis Oncology, Inc. (CLVS) | 17-Feb-15 | Market Option Sale (Planned) | 10,000 | $72.00 | $720,000.00 | (100%) 10.0K to 0 | 93% |
| 20-Jan-15 9:18 PM View: | Clovis Oncology, Inc. (CLVS) | 16-Jan-15 | Option Exercise | 10,000 | $11.02 | $110,200.00 | 100% 0 to 10.0K | |
| 20-Jan-15 9:18 PM View: | Clovis Oncology, Inc. (CLVS) | 16-Jan-15 | Market Option Sale (Planned) | 10,000 | $67.00 | $670,000.00 | (100%) 10.0K to 0 | 93% |